Trial uses enhanced cues to reduce alcohol and smoking
Part of Mental health clinical trials.
This Phase 2 study tests a program designed to help people cut down or stop heavy alcohol use and daily smoking at the same time. It will check your alcohol level at the start and uses urine tests during a short induction phase to confirm recent alcohol and ongoing smoking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- In the last 30 days, you drank heavily (at least 4 standard drinks in a day for women, or 5 for men) on at least 4 different occasions.
- You want treatment for both alcohol use disorder (AUD) and quitting smoking.
- You currently smoke daily and have a history of at least 100 lifetime cigarettes.
- At the consent visit, your breath alcohol level is 0.00 (no alcohol in your breath).
- During the start-up (induction) period, your urine must show alcohol use (EtG) and also show a second alcohol urine test (COT). You must also attend at least 4 of 6 visits during induction.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.
This trial tests a real-time e-counseling program to help adults quit smoking or vaping. It is designed for those who are motivated to stop using nicotine and set a quit date.
This study tests a virtual program that rewards you for reducing heavy drinking. You'd use a phone app, check in via Zoom, and get a glimpse into your drinking patterns through a blood test. It might be a good fit if you want to cut back on heavy drinking without going to an in-person clinic.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This study tests whether a drug called PT150 can help people with moderate to severe alcohol use disorder who are not currently seeking treatment. You will be asked to stay abstinent from alcohol for short periods and attend sessions to see how PT150 affects your body and alcohol cravings.
This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.
Hear when a new Nicotine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.